Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Diphenylcyclopropenone is effective and safe for treating severe alopecia areata in children, with maintenance therapy reducing relapse risk.

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.

Diphenylcyclopropenone treatment helps prevent hair loss relapse in alopecia areata patients.

Recombinant thrombomodulin can effectively treat severe complications in Cronkhite-Canada syndrome.

Combining DPCP with PRP doesn't improve hair regrowth in alopecia areata.

DEC cells show promise as a safe and effective treatment for Duchenne muscular dystrophy.

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

DPP may help hair regrowth by improving blood vessel function under stress.

Trilostane effectively and safely treats dogs with pituitary-dependent hyperadrenocorticism, improving symptoms and adrenal gland size.

The study found two new mutations in a Chinese patient with severe biotinidase deficiency.

The DPCP/HPβCD complex improves solubility and anti-inflammatory effects for alopecia areata treatment.

PTH-CBD agonists may help regrow hair after chemotherapy.

A cholesterol-free liposomal platform using protopanaxadiol effectively promotes hair growth and treats alopecia.

Polydopamine is promising for personalized medicine and biomedical technology due to its strong adhesion and biocompatibility.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.

Light therapy successfully treated a dog's hair growth problem without side effects.

DPCP alone is more effective and safer for treating chronic extensive alopecia areata than combining it with anthralin.

Diphencyprone initially increases mouse hair growth, then slows it, possibly due to changes in specific protein levels.

Early diagnosis and a multidisciplinary approach are crucial for children with Trichothiodystrophy and hidden learning disorders.

TTD patients don't have a higher skin cancer risk because their main issue is with transcription, not DNA repair.

Dutasteride may help protect neurons and reduce inflammation in Parkinson's disease.

Deep phenotyping helps distinguish between xeroderma pigmentosum and trichothiodystrophy, aiding in diagnosis and treatment.

DFMO treatment improves hair growth, muscle tone, and development in Bachmann-Bupp syndrome patients.

DPCP may be safe for treating alopecia during pregnancy, but more research is needed.

Tolvaptan can slow kidney disease progression, but doesn't affect mortality or kidney failure.

Combining DHT and EDC improves the strength and stability of PADM scaffolds for tissue engineering.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

Triptolide effectively and safely reduces actinic keratosis lesions in mice.

Beta-trace protein may help diagnose and predict treatment response in certain nerve disorders.

Tribuloside can increase skin pigmentation by enhancing melanin production and distribution.